Understanding the alloresponse: New approaches to graft-versus-host disease prevention
- 1 January 2002
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 39 (1) , 15-22
- https://doi.org/10.1053/shem.2002.29246
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationJournal of Clinical Investigation, 2001
- Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effectBlood, 2001
- A Fas-based suicide switch in human T cells for the treatment of graft-versus-host diseaseBlood, 2001
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- The Effect of Graft-versus-Host Disease on T Cell Production and HomeostasisThe Journal of Experimental Medicine, 1999
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.Journal of Clinical Investigation, 1998
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994